Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2018

  • ID: 4580446
  • Report
  • 116 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • BTG Plc
  • CardioGard Ltd.
  • Filterlex Medical Ltd
  • Keystone Heart Ltd
  • Metactive Medical LLC
  • MORE
Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • BTG Plc
  • CardioGard Ltd.
  • Filterlex Medical Ltd
  • Keystone Heart Ltd
  • Metactive Medical LLC
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Peripheral Embolic Protection Devices Overview

3 Products under Development
3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment
3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory
3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials

4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies
4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development

5 Peripheral Embolic Protection Devices Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allium Medical Solutions Ltd Company Overview
5.2.1 Allium Medical Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Avantec Vascular Corp Company Overview
5.3.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 BTG Plc Company Overview
5.4.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cardio-Flow Ltd. Company Overview
5.5.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.6 CardioGard Ltd. Company Overview
5.6.1 CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Emboline, Inc. Company Overview
5.7.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Filterlex Medical Ltd Company Overview
5.8.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Innovative Cardiovascular Solutions, LLC Company Overview
5.9.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Innovia LLC Company Overview
5.10.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Keystone Heart Ltd Company Overview
5.11.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medtronic plc Company Overview
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Metactive Medical LLC Company Overview
5.13.1 Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 MIV Therapeutics Inc Company Overview
5.14.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Neurosonix Ltd. Company Overview
5.15.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.16 Protembis GmbH Company Overview
5.16.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.17 Shape Memory Therapeutics, Inc. Company Overview
5.17.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Trinity College Dublin Company Overview
5.18.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Minnesota Company Overview
5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Toledo Company Overview
5.20.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview

6 Peripheral Embolic Protection Devices- Recent Developments
6.1 May 31, 2018: Keystone Heart Announces First Enrollment in REFLECT Phase II incorporating TriGUARD 3 Cerebral Embolic Protection device
6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.3 May 21, 2018: FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
6.4 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.5 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results
6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.7 Apr 27, 2018: Prospective Clinical Data on the FlowTriever System Confirms Excellent Results in the Treatment of Pulmonary Embolism
6.8 Apr 27, 2018: OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions
6.9 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.10 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.12 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
6.13 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.14 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.15 Mar 21, 2018: New Biocompatible Particle Embolic Device to Therapeutically Slow or Stop Blood Flow Presented at the 2018 Society of Interventional Radiology (SIR) Conference
6.16 Mar 13, 2018: United States Patent and Trademark Office Issues Multiple Patents on New Arterial & Venous Embolic Device to Control Bleeding, Seal Leaks, and De-Vascularize Tumors
6.17 Mar 08, 2018: Metactive Medical Awarded $1.5 Million Grant from the National Institutes of Health
6.18 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results
6.19 Feb 14, 2018: Claret Medical’s Sentinel Cerebral Protection System Emerging as U.S. Standard of Care for Protecting the Brain from Risk of Stroke During Transcatheter Aortic Heart Valve Replacement
6.20 Feb 06, 2018: OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism
6.21 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.22 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.23 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.24 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.25 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
6.26 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.27 Dec 14, 2017: Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS Therapy Protocols for Pulmonary Embolism
6.28 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.29 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.30 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.31 Nov 07, 2017: Penumbra Reports Third Quarter 2017 Financial Results
6.32 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.33 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.34 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.35 Oct 19, 2017: Inari Medical Announces Completion of Patient Enrollment in the FLARE Study for the Treatment of Pulmonary Embolism
6.36 Oct 18, 2017: Abrazo Arizona Heart and OhioHealth McConnell Heart Hospital To Use MegaVac System
6.37 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.38 Oct 05, 2017: Capture Continues with New Clinical Cases for its MegaVacTM Mechanical Thrombectomy System-ATK
6.39 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.40 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results
6.41 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
6.42 Sep 18, 2017: New Study Shows That Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality Associated with Transcatheter Aortic Valve Replacement (TAVR)
6.43 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.44 Sep 05, 2017: Protembis Announces Successful First-in-Human Use of Its ProtEmbo Cerebral Protection System in European Trial
6.45 Aug 23, 2017: New Technology Helps Protect PinnacleHealth Patients From Risk Of Stroke During Heart Valve Replacement
6.46 Aug 23, 2017: Capture Vascular Secures Updated FDA 510(k) Clearance
6.47 Aug 22, 2017: Malin Announces U.S. FDA Approval for New Hourglass Peripheral Embolisation Plug
6.48 Aug 22, 2017: Sacred Heart Uses New Device for Removing Blood Clots
6.49 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.50 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.51 Aug 08, 2017: Penumbra Reports Second Quarter 2017 Financial Results
6.52 Aug 01, 2017: Keystone Heart to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures
6.53 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.54 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
6.55 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.56 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
6.57 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.58 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer
6.59 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.60 Jun 16, 2017: ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
6.61 Jun 16, 2017: Sentinel Cerebral Protection System Used Commercially By TAVR Centers of Excellence Nationwide

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
Table 12: Allium Medical Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: WIRION EPD System - LE Atherectomy - Product Status
Table 14: WIRION EPD System - LE Atherectomy - Product Description
Table 15: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Peripheral Embolization Device - Product Status
Table 17: Peripheral Embolization Device - Product Description
Table 18: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: EkoSonic Endovascular System - Product Status
Table 20: EkoSonic Endovascular System - Product Description
Table 21: BTG Plc - Ongoing Clinical Trials Overview
Table 22: EkoSonic Endovascular System - Measure the Impact of Shorter, Even Safer EKOS Therapy Protocols for Pulmonary Embolism: KNOCOUT PE
Table 23: EkoSonic Endovascular System - Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism
Table 24: EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS
Table 25: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 26: EmboPRO EPD - Product Status
Table 27: EmboPRO EPD - Product Description
Table 28: CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 29: CardioGard 22 French Aortic Cannula - Product Status
Table 30: CardioGard 22 French Aortic Cannula - Product Description
Table 31: CardioGard Ltd. - Ongoing Clinical Trials Overview
Table 32: CardioGard 22 French Aortic Cannula - A Study to Collect Additional Information Related to the Performance of the CARDIOGARD Cannula
Table 33: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Emboliner - Product Status
Table 35: Emboliner - Product Description
Table 36: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Next Generation Embolic Protection Device - Product Status
Table 38: Next Generation Embolic Protection Device - Product Description
Table 39: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 40: EMBLOK Embolic Protection System - Product Status
Table 41: EMBLOK Embolic Protection System - Product Description
Table 42: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
Table 43: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Table 44: EMBLOK Embolic Protection System - Safety and Efficacy of EMBLOK Embolic Protection System in Patients with Severe Aortic Stenosis
Table 45: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Permanently Implantable Embolic Balloon - Product Status
Table 47: Permanently Implantable Embolic Balloon - Product Description
Table 48: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: TriGuard 3 - Product Status
Table 50: TriGuard 3 - Product Description
Table 51: TriGuard Cerebral Protection Device - Product Status
Table 52: TriGuard Cerebral Protection Device - Product Description
Table 53: Keystone Heart Ltd - Ongoing Clinical Trials Overview
Table 54: TriGuard Cerebral Protection Device - A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions after Transcatheter Aortic Valve Implantation
Table 55: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: SilverHawk With SpiderFX Embolic Protection Device - Product Status
Table 57: SilverHawk With SpiderFX Embolic Protection Device - Product Description
Table 58: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Blockstent Microcatheter - Product Status
Table 60: Blockstent Microcatheter - Product Description
Table 61: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Aortic Embolic Protection Device - Product Status
Table 63: Aortic Embolic Protection Device - Product Description
Table 64: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Protection Collar - Product Status
Table 66: Protection Collar - Product Description
Table 67: Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 68: ProtEmbo System - Product Status
Table 69: ProtEmbo System - Product Description
Table 70: Protembis GmbH - Ongoing Clinical Trials Overview
Table 71: ProtEmbo System - Cerebral Protection in Transcatheter Aortic Valve Replacement
Table 72: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 73: IMPEDE - Product Status
Table 74: IMPEDE - Product Description
Table 75: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Transcatheter Device - Atherosclerotic Plaque - Product Status
Table 77: Transcatheter Device - Atherosclerotic Plaque - Product Description
Table 78: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Embolic Protection Device - Product Status
Table 80: Embolic Protection Device - Product Description
Table 81: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Minimally Invasive Thrombectomy Device - Product Status
Table 83: Minimally Invasive Thrombectomy Device - Product Description
Table 84: Glossary

List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Vascular Inc
  • Allium Medical Solutions Ltd
  • Avantec Vascular Corp
  • BTG Plc
  • Cardio-Flow Ltd.
  • CardioGard Ltd.
  • Emboline, Inc.
  • Filterlex Medical Ltd
  • Innovative Cardiovascular Solutions, LLC
  • Innovia LLC
  • Keystone Heart Ltd
  • Medtronic plc
  • Metactive Medical LLC
  • MIV Therapeutics Inc
  • Neurosonix Ltd.
  • Protembis GmbH
  • Shape Memory Therapeutics, Inc.
  • Trinity College Dublin
  • University of Minnesota
  • University of Toledo
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll